Results 211 to 220 of about 80,577 (303)
Research progress in electrochemical determination of Janus kinase inhibitors and proposals for amplifying clinical applicability. [PDF]
Mikus P, Hanko M, Zelinkova Z, Labuda J.
europepmc +1 more source
A panel of 18 dermatologists participated in a three‐round Delphi‐based consensus process to generate a standardized framework for the diagnosis and management of alopecia areata (AA) in Asia Pacific. Recommendations focus on practicality and clinical relevance within the regional context.
Rodney Sinclair +17 more
wiley +1 more source
Janus Kinase Inhibitor Discontinuation at a UK Tertiary Centre: A Retrospective Study. [PDF]
Bland K, Jubber A, Ganguly S, Moorthy A.
europepmc +1 more source
Multilingual vitiligo‐related Google search queries in Germany (October 2019–May 2023) were extracted and thematically coded across German, English, Turkish, Arabic, Russian, and Polish. Relative patterns highlighted language‐specific emphases in treatment information, camouflage, depigmentation, psychosocial burden, and faith/home‐remedy terms ...
Lilian Rauch +5 more
wiley +1 more source
Treatment of Livedoid Vasculopathy with the Janus Kinase Inhibitors: A Case Series. [PDF]
Zhao G, Liu Y, Ni J, Song Z.
europepmc +1 more source
Ritlecitinib induced rapid clinical improvement in moderate‐to‐severe alopecia areata in real‐world practice. Early change in SALT at Week 12 strongly discriminated Week‐24 responders, supporting a pragmatic treat‐to‐target checkpoint, alongside improvements in clinician‐reported and patient‐reported outcomes and a favorable safety profile.
Giuseppe Gallo +4 more
wiley +1 more source
Acute retinal necrosis during the systemic use of Janus kinase inhibitor. [PDF]
Watanabe D +12 more
europepmc +1 more source
The psoriasis–atopic dermatitis interface: four clinical phenotypes (coexisting, overlapping, biologic‐induced eczema, dupilumab‐induced psoriasis) across 105 patients from two Italian tertiary centers. JAK inhibitors achieved the highest response rates across all phenotypes, reflecting their mechanistic rationale targeting shared JAK‐STAT downstream ...
Michela D'Agostino +8 more
wiley +1 more source
Management of Pregnancy in Women with Inflammatory Bowel Disease: Positioning Janus Kinase Inhibitors Within Current Evidence. [PDF]
Colacurci D +12 more
europepmc +1 more source
JAK inhibitors and menstrual cycle alterations: insights from a case series of 16 female patients
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Luciano Ibba +11 more
wiley +1 more source

